Skip to content

Ayurvedic medication in the treatment of Major Depressive Disorder

Efficacy Of Jatamansi Arka And Sarpagandhaghana Vati In Major Depressive Disorder - A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047682
Enrollment
50
Registered
2022-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

None listed

Sponsors

Dr Kavya Shree S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals between the age group of 20 to 60 years 2.Patients of Either sex 3.Subjects fulfilling the diagnostic criteria DSM 5

Exclusion criteria

Exclusion criteria: 1.Patients with Axis II disorder like personality disorders ? 2.Patients with other Axis I disorders like schizophrenia psychosis Anxiety disorders etc 3.Evidence of active suicidal ideation? 4.Depression with Psychotic symptoms? 5.Use of Psychotropics therapy drugs within the past period of 4 weeks? 6.Pregnant or lactating women? 7.Any other Chronic illness like Diabetes mellitus Cardiovascular diseases

Design outcomes

Primary

MeasureTime frame
Primary outcome of MDD on the basis of MADRS in 60 DaysTimepoint: Base line 15days 30days 45days 60days

Secondary

MeasureTime frame
Secondary Outcome of MDD on the basis of CGI-Clinical Global Impression-Severity Index Global Improvement Efficacy Index, BHS-Becks Hopelessness Scale, WHO QOL BREF-World Health Organization Quality Of Life Bref, PSQI-Pittsberg Sleep Quality Index, UKU- UKU Side Effect Rating Scale, HAM-A-Hamilton Anxiety rating Scale in 60daysTimepoint: Baseline, 15days, 30days, 45days, 60days

Countries

India

Contacts

Public ContactDr Basavaraj R Tubaki

KAHERs Shri BMK Ayurveda Mahavidhyalaya Shahapur Belagavi

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026